Scarica l'app Stockscreener
1.87
0.54%
0.01
Dopo l'orario di chiusura:
1.96
0.09
+4.81%
Precedente Chiudi:
$1.86
Aprire:
$1.88
Volume 24 ore:
240.30K
Relative Volume:
0.42
Capitalizzazione di mercato:
$97.83M
Reddito:
$21.05M
Utile/perdita netta:
$-89.22M
Rapporto P/E:
-1.0447
EPS:
-1.79
Flusso di cassa netto:
$-64.50M
1 W Prestazione:
-1.06%
1M Prestazione:
+11.31%
6M Prestazione:
-25.79%
1 anno Prestazione:
-73.44%
Intervallo 1D:
$1.8284
$1.90
Intervallo di 1 settimana:
$1.75
$1.91
Portata 52W:
$1.02
$7.44
Tscan Therapeutics Inc Stock (TCRX) Company Profile
Nome
Tscan Therapeutics Inc
Settore
Industria
Telefono
857-399-9500
Indirizzo
880 WINTER STREET, WALTHAM
Confronta TCRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TCRX
Tscan Therapeutics Inc
|
1.87 | 104.69M | 21.05M | -89.22M | -64.50M | -1.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Tscan Therapeutics Inc Stock (TCRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-05-16 | Iniziato | BTIG Research | Buy |
| 2024-05-13 | Iniziato | Needham | Buy |
| 2023-06-22 | Iniziato | Wedbush | Outperform |
Tscan Therapeutics Inc Borsa (TCRX) Ultime notizie
Does TScan Therapeutics Inc. stock pay reliable dividendsDynamic capital growth - jammulinksnews.com
How high can TScan Therapeutics Inc. stock price go in 2025Game-changing returns - jammulinksnews.com
What analysts say about TScan Therapeutics Inc. stockExponential return rates - Autocar Professional
TScan Therapeutics Inc. Stock Analysis and ForecastJaw-dropping returns - Autocar Professional
Is TScan Therapeutics Inc. a good long term investmentFree Capital Efficiency Planning - Autocar Professional
What drives TScan Therapeutics Inc. stock priceTremendous return rates - jammulinksnews.com
One TScan Therapeutics Insider Raised Stake By 18% In Previous Year - Yahoo.co
Why TScan Therapeutics Inc. stock attracts strong analyst attentionStrategic High Profit Opportunities - Newser
How TScan Therapeutics Inc. stock performs during market volatilityShort Term High Return Strategy - Newser
What makes TScan Therapeutics Inc. stock price move sharplyFree Access to Community with 300% Return - Newser
TScan Therapeutics (NASDAQ:TCRX) Rating Increased to Hold at Wall Street Zen - Defense World
Great week for TScan Therapeutics, Inc. (NASDAQ:TCRX) institutional investors after losing 73% over the previous year - simplywall.st
TScan Therapeutics, Inc. (NASDAQ:TCRX) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
TScan Therapeutics (NASDAQ:TCRX) Stock Price Down 4% – Time to Sell? - Defense World
TScan Therapeutics Elects New Directors at Annual Meeting - TipRanks
TScan Therapeutics elects directors and ratifies auditor at annual meeting - Investing.com
TScan Therapeutics, Inc.(NasdaqGM: TCRX) dropped from Russell Microcap Growth Index - MarketScreener
Analysts Set TScan Therapeutics, Inc. (NASDAQ:TCRX) PT at $7.80 - Defense World
Wall Street Zen Downgrades TScan Therapeutics (NASDAQ:TCRX) to Sell - Defense World
Bank of America Corp DE Has $456,000 Holdings in TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World
Squarepoint Ops LLC Makes New $59,000 Investment in TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World
Wellington Management Group LLP Boosts Stock Holdings in TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World
ProShare Advisors LLC Makes New $40,000 Investment in TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World
BNP Paribas Financial Markets Makes New Investment in TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World
TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare Conference - GlobeNewswire
Cancer Therapy Pioneer TScan Therapeutics Set for Major Presentation at Jefferies Healthcare Conference - Stock Titan
TScan Therapeutics’ SWOT analysis: biotech firm’s stock faces pivotal year By Investing.com - Investing.com South Africa
TScan Therapeutics’ SWOT analysis: biotech firm’s stock faces pivotal year - Investing.com
Analysts Have Conflicting Sentiments on These Healthcare Companies: Novo Nordisk (NVO), Beam Therapeutics (BEAM) and TScan Therapeutics (TCRX) - The Globe and Mail
Tscan Therapeutics Inc Azioni (TCRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):